Merve Yavuz

Merve Yavuz

Auto-generated profile, based on publicly available information

Merve Yavuz

Department of Pediatric Neurology, Gaziantep City Hospital, Gaziantep, Türkiye

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2023 in Pediatrics International
Verified
Journal Article
Closed access
YGYiğithan Güzin
Yiğithan Güzin
UYUnsal Yılmaz
Unsal Yılmaz
SPSerdar Pekuz
Serdar Pekuz
PKPakize Karaoğlu
Pakize Karaoğlu
IIİpEk Burcu Parlak İbIş
İpEk Burcu Parlak İbIş
AÜAycan Ünalp
Aycan Ünalp

7 September 2023 in The Journal of Pediatric Academy
Verified
Journal Article
Open access
PDF file
AÜAycan Ünalp
Aycan Ünalp
PKPakize Karaoğlu
Pakize Karaoğlu
MYMerve Yavuz
Merve Yavuz
IIİpek Burcu Parlak İbiş
İpek Burcu Parlak İbiş
ÜYÜnsal Yılmaz
Ünsal Yılmaz
The Coronavirus disease-2019 pandemic has led to the spread of telemedicine management of ketogenic diet therapy (KDT) in children with drug-resistant epilepsy (DRE). In this study, we evaluated the views and satisfaction of families about telemedicine and KDT management. Families of 25 children who underwent KDT for DRE were included in the 17-item questionnaire. Nearly half of the families had a primary education level. Most children with DRE were in the process of maintaining KDT. 88% of the families were applying KDT with telemedicine due to the pandemic. 60% of families found it difficult to start KDT via telemedicine, but 96% reported that reaching the KDT team via telemedicine was sufficient. The necessity of laboratory analyzes and evaluation of the results of the KDT team was evaluated as good in 72%, and their response when dietary changes or vitamin addition was required was evaluated as good in 68%. All families were satisfied with the management of the KDT team in emergencies. 60% of the family recommended others to follow the KDT with telemedicine at all times and 40% recommended them during the pandemic period. According to the results of our study, in selecting patients who will be started with telemedicine and KDT, it should be noted that the families have sufficient education levels. The use of the telemedicine method may be a good option in the presence of an experienced and trained team in KDT management.

15 April 2026 in Therapeutic Apheresis and Dialysis
Verified
Journal Article
Closed access
PDF file
IBIbrahim Bingöl
Ibrahim Bingöl
MYMerve Yavuz
Merve Yavuz
HUHacer Ucmak
Hacer Ucmak

27 March 2026 in European Journal of Paediatric Neurology
Verified
Journal Article
Closed access
MYMerve Yavuz
Merve Yavuz
ÜYÜnsal Yılmaz
Ünsal Yılmaz
FGFeyza Gülağız
Feyza Gülağız
YGYiğithan Güzin
Yiğithan Güzin
SPSerdar Pekuz
Serdar Pekuz
AÜAycan Ünalp
Aycan Ünalp


31 December 2024 in Trends in Pediatrics
Verified
Journal Article
Open access
PDF file
YGYiğithan Güzin
Yiğithan Güzin
SPSerdar Pekuz
Serdar Pekuz
PKPakize Karaoğlu
Pakize Karaoğlu
IIİpEk Burcu Parlak İbIş
İpEk Burcu Parlak İbIş
HKHatice Hilal Kırkgöz
Hatice Hilal Kırkgöz
ÜYÜnsal Yılmaz
Ünsal Yılmaz
Objectives: West syndrome (WS) is an early childhood epileptic encephalopathy characterized by spasms, typically occurring within the first year of life. The International League Against Epilepsy reclassified WS as “infantile epileptic spasm syndrome” to enhance early diagnosis and treatment. It is marked by a triad of epileptic spasms, psychomotor retardation or regression, and hypsarrhythmia on EEG. The prognosis and response to classical anti-epileptic treatments are often poor, and factors influencing prognosis remain unclear. Methods: This study retrospectively analyzed 75 patients with WS over five years, assessing etiology, MRI findings, and neurodevelopmental outcomes according to ILAE guidelines. Results: The cohort comprised 35 females (46.7%) and 40 males (53.3%). The most common etiology was structural, observed in 41 patients (54.7%), followed by unknown causes in 19 patients (25.3%). Genetic, metabolic, and infectious causes were less common. Brain MRI findings were normal in 23 patients (30.7%). Treatment primarily involved Vigabatrin, which was used in 54.7% of cases, followed by Adrenocorticotropic hormone (ACTH) in 25.3%. Seizure control improved over time, with 24% of patients fully controlled at one year and 42.8% at five years. However, 28% showed no change in seizure frequency. The presence of structural abnormalities correlated with a poorer prognosis, while early and complete seizure control was associated with better outcomes. Mortality was 5.3%, with four patients passing away during the follow-up period. Conclusion: The study highlights that while the etiology remains a significant factor in the prognosis of WS, early intervention and effective seizure management are crucial for improving long-term outcomes.